DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 144 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q4 2021. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $142,210 | -26.6% | 11,180 | -18.8% | 0.00% | -50.0% |
| Q2 2023 | $193,868 | -17.0% | 13,769 | -9.0% | 0.00% | 0.0% |
| Q1 2023 | $233,712 | +26.0% | 15,127 | +33.7% | 0.00% | 0.0% |
| Q4 2022 | $185,420 | -7.3% | 11,313 | +4.8% | 0.00% | 0.0% |
| Q3 2022 | $200,000 | +94.2% | 10,797 | -2.4% | 0.00% | +100.0% |
| Q1 2022 | $103,000 | -3.7% | 11,066 | +1.2% | 0.00% | 0.0% |
| Q4 2021 | $107,000 | -71.5% | 10,935 | -1.1% | 0.00% | -66.7% |
| Q3 2021 | $376,000 | -6.2% | 11,052 | +0.8% | 0.00% | 0.0% |
| Q2 2021 | $401,000 | -17.0% | 10,965 | +1.8% | 0.00% | -25.0% |
| Q1 2021 | $483,000 | -20.4% | 10,773 | +1.4% | 0.00% | -33.3% |
| Q4 2020 | $607,000 | +8.0% | 10,628 | -3.0% | 0.01% | 0.0% |
| Q3 2020 | $562,000 | +18.3% | 10,956 | +37.7% | 0.01% | -14.3% |
| Q2 2020 | $475,000 | +92.3% | 7,955 | +32.8% | 0.01% | +75.0% |
| Q1 2020 | $247,000 | – | 5,992 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 1,209,571 | $69,030,000 | 15.95% |
| SV Health Investors, LLC | 449,951 | $25,679,000 | 12.37% |
| Sunesis Advisors, LLC | 96,299 | $5,496,000 | 4.45% |
| Redmile Group, LLC | 4,437,968 | $253,275,000 | 3.07% |
| Consonance Capital Management LP | 484,671 | $27,660,000 | 2.58% |
| SECTORAL ASSET MANAGEMENT INC | 488,842 | $27,898,000 | 1.97% |
| Opaleye Management Inc. | 222,000 | $12,670,000 | 1.66% |
| Eversept Partners, LP | 246,240 | $14,052,917 | 1.65% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 38,620 | $2,204,000 | 1.28% |
| Avoro Capital Advisors LLC | 1,300,000 | $74,191,000 | 1.28% |